Published on in Vol 6, No 12 (2017): December

Mobile Health Technology (mDiab) for the Prevention of Type 2 Diabetes: Protocol for a Randomized Controlled Trial

Mobile Health Technology (mDiab) for the Prevention of Type 2 Diabetes: Protocol for a Randomized Controlled Trial

Mobile Health Technology (mDiab) for the Prevention of Type 2 Diabetes: Protocol for a Randomized Controlled Trial

Journals

  1. Xie R, Tan H, Taljaard M, Liao Y, Krewski D, Du Q, Wen S. The Impact of a Maternal Education Program Through Text Messaging in Rural China: Cluster Randomized Controlled Trial. JMIR mHealth and uHealth 2018;6(12):e11213 View
  2. Gupta U, Gupta Y, Jose D, Mani K, Jyotsna V, Sharma G, Tandon N. Effectiveness of a Video-Based Lifestyle Education Program Compared to Usual Care in Improving HbA1c and Other Metabolic Parameters in Individuals with Type 2 Diabetes: An Open-Label Parallel Arm Randomized Control Trial (RCT). Diabetes Therapy 2020;11(3):667 View
  3. Vehi J, Regincós Isern J, Parcerisas A, Calm R, Contreras I. Impact of Use Frequency of a Mobile Diabetes Management App on Blood Glucose Control: Evaluation Study. JMIR mHealth and uHealth 2019;7(3):e11933 View
  4. Klonoff D. Behavioral Theory: The Missing Ingredient for Digital Health Tools to Change Behavior and Increase Adherence. Journal of Diabetes Science and Technology 2019;13(2):276 View
  5. Schiel R, Bambauer R, Steveling A. Technology in Diabetes Treatment: Update and Future. Artificial Organs 2018;42(11):1017 View
  6. Balaji B, Ranjit Mohan A, Rajendra P, Mohan D, Ram U, Viswanathan M. Gestational Diabetes Mellitus Postpartum Follow-Up Testing: Challenges and Solutions. Canadian Journal of Diabetes 2019;43(8):641 View
  7. Gopalan H, Misra A, Jayawardena R. Nutrition and diabetes in South Asia. European Journal of Clinical Nutrition 2018;72(9):1267 View
  8. Sidhu A, Kumar S, Wipfli H, Arora M, Valente T. International Approaches to Tobacco Prevention and Cessation Programming and Policy among Adolescents in India. Current Addiction Reports 2018;5(1):10 View
  9. Muralidharan S, Ranjani H, Mohan Anjana R, Jena S, Tandon N, Gupta Y, Ambekar S, Koppikar V, Jagannathan N, Allender S, Mohan V. Engagement and Weight Loss: Results from the Mobile Health and Diabetes Trial. Diabetes Technology & Therapeutics 2019;21(9):507 View
  10. Thomaschewski M, Beyer F, Thomaschewski M, Ellebrecht D, Jonczyk M, Schneider M, Keck T, Mentler T, Hummel R. Application-based management of perioperative anticoagulant therapy: description of POPACTApp. Langenbeck's Archives of Surgery 2019;404(5):633 View
  11. Kumar D, Bhardwaj A, Sharma S, Malhotra B, Amadi-Mgbenka C, Grover A, Joshi A. Designing and Evaluating a Personalized, Human-Centered Dietary Decision Support System for Use Among People With Diabetes in an Indian Setting: Protocol for a Quasi-Experimental Study. JMIR Research Protocols 2022;11(3):e13635 View
  12. Jiménez S, Juárez-Ramírez R, Ramírez-Noriega A, Murillo-Muñoz F, Molina A, Castillo V, Navarro-Cota C. A Usability and Persuasion Evaluation of Mobile Apps for Diabetes Type 2. Programming and Computer Software 2022;48(8):552 View
  13. Kesavadev J, Krishnan G, Mohan V. Digital health and diabetes: experience from India. Therapeutic Advances in Endocrinology and Metabolism 2021;12 View
  14. Hamasaki H. Efficacy of Wearable Devices to Measure and Promote Physical Activity in the Management of Diabetes. EMJ Diabetes 2018:62 View
  15. Muralidharan S, Ranjani H, Anjana R, Gupta Y, Ambekar S, Koppikar V, Jagannathan N, Jena S, Tandon N, Allender S, Mohan V. Change in cardiometabolic risk factors among Asian Indian adults recruited in a mHealth-based diabetes prevention trial. DIGITAL HEALTH 2021;7 View
  16. Han C, Zhang J, Ye X, Lu J, Jin H, Xu W, Wang P, Zhang M. Telemedicine-assisted structured self-monitoring of blood glucose in management of T2DM results of a randomized clinical trial. BMC Medical Informatics and Decision Making 2023;23(1) View
  17. Seixas A, Richards S, Moore J, Izeogu C, Hollimon L, Jin P, Jean-Louis G. Precision Recruitment and Engagement of Individuals at Risk for Diabetes and Hypertension in Clinical Trials (PREDHICT): A Randomized Trial for an E-Persuasive Mobile Application to Inform Decision Making about Clinical Trials. International Journal of Environmental Research and Public Health 2023;20(23):7115 View
  18. Rahim E, Rahim F, Anzaar H, Lalwani P, Jain B, Desai A, Palakodeti S. Culturally Tailored Strategies to Enhance Type 2 Diabetes Care for South Asians in the United States. Journal of General Internal Medicine 2024;39(13):2560 View